Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakshmi Amaravadi

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Bioanalysis|April 23, 2021
Critical reagents: evolution of WRIB recommendations on critical reagentsLakshmi Amaravadi
Bioanalysis|November 19, 2016
Biomarker measurements: how far have we come and where are we heading?Lakshmi Amaravadi
Bioanalysis|February 22, 2013
Mini Focus: bioanalysis of biosimilarsLakshmi Amaravadi, Joseph Marini
Bioanalysis|May 26, 2021
Current and effective strategies for critical reagent characterization, storage, stability, retesting and life cycle management for ligand-binding assays and flow cytometryLakshmi Amaravadi, Nisha Palackal, Fabio Garofolo
Journal of Immunological Methods|April 23, 2013
Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assayYuhong Xiang, Mackenzie Welch, Lakshmi Amaravadi, et al.
Journal of Immunological Methods|December 7, 2010
Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug developmentAlvydas Mikulskis, Dave Yeung, Meena Subramanyam, et al.
Bioanalysis|March 11, 2011
Paradigm of combination biologics: analytical challenges related to pharmacokinetic assays and interpretation of pharmacokinetic and immunogenicity resultsLauren Stevenson, Kimberly Zinnack, Jean Donley, et al.
Journal of Immunological Methods|April 2, 2013
Novel data analysis methods to overcome cut point challenges and enable comprehensive assessment of antidrug binding activity in confirmatory assaysAlvydas Mikulskis, Dave Yeung, Weiping Chen, et al.
Bioanalysis|May 17, 2017
Recommendations for clinical biomarker specimen preservation and stability assessmentsNaveen Dakappagari, Hui Zhang, Laurie Stephen, et al.
Journal of Immunological Methods|November 7, 2009
A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distributionBrian Schlain, Lakshmi Amaravadi, Jean Donley, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Bioanalysis|April 23, 2021
Critical reagents: evolution of WRIB recommendations on critical reagentsLakshmi Amaravadi
Bioanalysis|November 19, 2016
Biomarker measurements: how far have we come and where are we heading?Lakshmi Amaravadi
Bioanalysis|February 22, 2013
Mini Focus: bioanalysis of biosimilarsLakshmi Amaravadi, Joseph Marini
Bioanalysis|May 26, 2021
Current and effective strategies for critical reagent characterization, storage, stability, retesting and life cycle management for ligand-binding assays and flow cytometryLakshmi Amaravadi, Nisha Palackal, Fabio Garofolo
Journal of Immunological Methods|April 23, 2013
Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assayYuhong Xiang, Mackenzie Welch, Lakshmi Amaravadi, et al.
Journal of Immunological Methods|December 7, 2010
Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug developmentAlvydas Mikulskis, Dave Yeung, Meena Subramanyam, et al.
Bioanalysis|March 11, 2011
Paradigm of combination biologics: analytical challenges related to pharmacokinetic assays and interpretation of pharmacokinetic and immunogenicity resultsLauren Stevenson, Kimberly Zinnack, Jean Donley, et al.
Journal of Immunological Methods|April 2, 2013
Novel data analysis methods to overcome cut point challenges and enable comprehensive assessment of antidrug binding activity in confirmatory assaysAlvydas Mikulskis, Dave Yeung, Weiping Chen, et al.
Bioanalysis|May 17, 2017
Recommendations for clinical biomarker specimen preservation and stability assessmentsNaveen Dakappagari, Hui Zhang, Laurie Stephen, et al.
Journal of Immunological Methods|November 7, 2009
A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distributionBrian Schlain, Lakshmi Amaravadi, Jean Donley, et al.
Pageof 4